Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MFinity BE Pre-market Trial

NCT: NCT07616895 · NOT_YET_RECRUITING

NCT IDNCT07616895
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2029-06
SponsorMedacta International SA (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this trial is to determine the implant survival at 1 year of follow up in a population of patients undergoing primary Total Hip Replacement with MFinity Collared Femoral stem and to test its non-inferiority compared to other cementless implant (as reported by the EPRD registry).

Frequently Asked Questions

What is MFinity BE Pre-market Trial?

MFinity BE Pre-market Trial is a clinical trial registered under NCT07616895. Current status: NOT_YET_RECRUITING.

What is the status of NCT07616895?

The current status of NCT07616895 (MFinity BE Pre-market Trial) is: NOT_YET_RECRUITING.

When did MFinity BE Pre-market Trial start?

MFinity BE Pre-market Trial started on 2026-06.

Related Devices

K153664M.U.S.T. Pedicle Screw SystemMedacta International K160289MasterLoc StemMedacta International K160605MectaLIF Anterior Stand-AloneMedacta International K261016MSS - Humeral reverse liners extensionMedacta International, SA K182705Juveno Hip System Femoral Stem, b-ONE Primary Acetabular System CupsB-One Ortho, Corp.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑